FDA-LAMOTRIGINE › Recommendations for Premarket Notifications for Lamotrigine and Zonisamide Assays - Guidance for Industry and Food and Drug Administration Staff

FDA-LAMOTRIGINE - 2016 EDITION - CURRENT



Recommendations for Premarket Notifications for Lamotrigine and Zonisamide Assays - Guidance for Industry and Food and Drug Administration Staff


This document comes with our free Notification Service, good for the life of the document.

This document is available in either Paper or PDF format.

ORDER

Price:

$20.00        




Document Number

1654

Revision Level

2016 EDITION

Status

Current

Publication Date

Feb. 9, 2016

Page Count

20 pages